At the University Hospital Tübingen, the translationally oriented Department of Peptide-based Immunotherapy, led by Prof. Juliane Walz, studies and develops T cell-based immunotherapies for infectious and tumor diseases. Our main goal is to quickly transfer promising research findings in the field of peptide-based immunotherapy into clinical applications for patients.
As a result, our department includes both an application-oriented research area, which investigates the mechanisms of T cell-mediated immune recognition of tumors and virus-infected cells via HLA-presented peptides and develops new immunotherapy concepts, as well as a Wirkstoffpeptidlabor, which in a next step produces the peptides for clinical trials.
